Mymetics Corporation
MYMX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -81.6% | 6,611.4% | -97.5% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | -$0 | -$0 | -$1 | -$0 |
| % Margin | -62.2% | -5% | -19,866.7% | -112.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -1,030.1% | -144.5% | -40,033.3% | -411.6% |
| Other Income/Exp. Net | -$1 | -$7 | -$1 | -$0 |
| Pre-Tax Income | -$1 | -$8 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$8 | -$2 | -$1 |
| % Margin | -3,012% | -3,816.9% | -62,033.3% | -766.5% |
| EPS | -7.33 | -0.025 | -0.003 | -0.004 |
| % Growth | -28,872.3% | -716.1% | 29.5% | – |
| EPS Diluted | -7.33 | -0.025 | -0.003 | -0.004 |
| Weighted Avg Shares Out | 304 | 304 | 304 | 304 |
| Weighted Avg Shares Out Dil | 304 | 304 | 304 | 304 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$7 | -$1 | -$0 |
| % Margin | -1,084.2% | -3,462.3% | -38,700% | -168.2% |